vs
Side-by-side financial comparison of Elme Communities (ELME) and 4D Molecular Therapeutics, Inc. (FDMT). Click either name above to swap in a different company.
4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $62.1M, roughly 1.4× Elme Communities). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs -198.9%, a 221.7% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 1.7%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $7.2M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 2.7%).
Elme Communities is a publicly traded U.S. real estate investment trust that primarily owns, operates and develops high-quality multifamily residential communities. It focuses on key growth markets across the U.S. Mid-Atlantic and Southeast, offering affordable to mid-tier housing options for diverse renter groups.
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
ELME vs FDMT — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $85.1M |
| Net Profit | $-123.5M | $19.4M |
| Gross Margin | 61.1% | — |
| Operating Margin | -183.3% | 17.3% |
| Net Margin | -198.9% | 22.8% |
| Revenue YoY | 1.7% | 8508900.0% |
| Net Profit YoY | -4058.7% | 139.1% |
| EPS (diluted) | $-1.40 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $85.1M | ||
| Q3 25 | $62.1M | $90.0K | ||
| Q2 25 | $62.1M | $15.0K | ||
| Q1 25 | $61.5M | $14.0K | ||
| Q4 24 | $61.3M | $1.0K | ||
| Q3 24 | $61.1M | $3.0K | ||
| Q2 24 | $60.1M | $5.0K | ||
| Q1 24 | $59.5M | $28.0K |
| Q4 25 | — | $19.4M | ||
| Q3 25 | $-123.5M | $-56.9M | ||
| Q2 25 | $-3.6M | $-54.7M | ||
| Q1 25 | $-4.7M | $-48.0M | ||
| Q4 24 | $-3.0M | — | ||
| Q3 24 | $-3.0M | $-43.8M | ||
| Q2 24 | $-3.5M | $-35.0M | ||
| Q1 24 | $-3.6M | $-32.4M |
| Q4 25 | — | — | ||
| Q3 25 | 61.1% | — | ||
| Q2 25 | 63.5% | — | ||
| Q1 25 | 64.2% | — | ||
| Q4 24 | 62.9% | — | ||
| Q3 24 | 63.5% | — | ||
| Q2 24 | 63.4% | — | ||
| Q1 24 | 63.5% | — |
| Q4 25 | — | 17.3% | ||
| Q3 25 | -183.3% | -67983.3% | ||
| Q2 25 | 9.6% | -396373.3% | ||
| Q1 25 | 7.8% | -383007.1% | ||
| Q4 24 | 10.4% | — | ||
| Q3 24 | 11.0% | -1704400.0% | ||
| Q2 24 | 9.8% | -849120.0% | ||
| Q1 24 | 7.5% | -136200.0% |
| Q4 25 | — | 22.8% | ||
| Q3 25 | -198.9% | -63195.6% | ||
| Q2 25 | -5.7% | -364386.7% | ||
| Q1 25 | -7.6% | -342657.1% | ||
| Q4 24 | -4.9% | — | ||
| Q3 24 | -4.9% | -1461433.3% | ||
| Q2 24 | -5.8% | -699060.0% | ||
| Q1 24 | -6.1% | -115717.9% |
| Q4 25 | — | $0.43 | ||
| Q3 25 | $-1.40 | $-1.01 | ||
| Q2 25 | $-0.04 | $-0.98 | ||
| Q1 25 | $-0.05 | $-0.86 | ||
| Q4 24 | $-0.04 | — | ||
| Q3 24 | $-0.03 | $-0.79 | ||
| Q2 24 | $-0.04 | $-0.63 | ||
| Q1 24 | $-0.04 | $-0.66 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.1M | $402.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $908.9M | $505.7M |
| Total Assets | $1.7B | $566.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $402.7M | ||
| Q3 25 | $7.1M | $305.1M | ||
| Q2 25 | $4.8M | $293.2M | ||
| Q1 25 | $6.4M | $321.4M | ||
| Q4 24 | $6.1M | $424.9M | ||
| Q3 24 | $4.8M | $501.9M | ||
| Q2 24 | $5.6M | $541.9M | ||
| Q1 24 | $4.2M | $525.9M |
| Q4 25 | — | $505.7M | ||
| Q3 25 | $908.9M | $369.0M | ||
| Q2 25 | $1.0B | $420.9M | ||
| Q1 25 | $1.1B | $469.7M | ||
| Q4 24 | $1.1B | $510.6M | ||
| Q3 24 | $1.1B | $552.9M | ||
| Q2 24 | $1.1B | $588.3M | ||
| Q1 24 | $1.1B | $600.6M |
| Q4 25 | — | $566.7M | ||
| Q3 25 | $1.7B | $424.0M | ||
| Q2 25 | $1.8B | $473.6M | ||
| Q1 25 | $1.8B | $515.7M | ||
| Q4 24 | $1.8B | $560.4M | ||
| Q3 24 | $1.9B | $604.0M | ||
| Q2 24 | $1.9B | $620.1M | ||
| Q1 24 | $1.9B | $629.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $15.9M | $28.6M |
| Free Cash FlowOCF − Capex | $7.2M | $28.5M |
| FCF MarginFCF / Revenue | 11.6% | 33.5% |
| Capex IntensityCapex / Revenue | 14.0% | 0.1% |
| Cash ConversionOCF / Net Profit | — | 1.47× |
| TTM Free Cash FlowTrailing 4 quarters | $86.7M | $-109.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $28.6M | ||
| Q3 25 | $15.9M | $-46.5M | ||
| Q2 25 | $29.8M | $-43.4M | ||
| Q1 25 | $16.2M | $-47.8M | ||
| Q4 24 | $95.2M | $-134.6M | ||
| Q3 24 | $20.7M | $-29.4M | ||
| Q2 24 | $28.9M | $-30.2M | ||
| Q1 24 | $21.2M | $-29.1M |
| Q4 25 | — | $28.5M | ||
| Q3 25 | $7.2M | $-46.6M | ||
| Q2 25 | $21.1M | $-43.4M | ||
| Q1 25 | $10.5M | $-48.4M | ||
| Q4 24 | $47.9M | $-138.4M | ||
| Q3 24 | $8.8M | $-31.2M | ||
| Q2 24 | $21.0M | $-30.6M | ||
| Q1 24 | $7.6M | $-29.8M |
| Q4 25 | — | 33.5% | ||
| Q3 25 | 11.6% | -51765.6% | ||
| Q2 25 | 34.1% | -289620.0% | ||
| Q1 25 | 17.1% | -345635.7% | ||
| Q4 24 | 78.1% | -13837100.0% | ||
| Q3 24 | 14.4% | -1038966.7% | ||
| Q2 24 | 34.9% | -611840.0% | ||
| Q1 24 | 12.8% | -106421.4% |
| Q4 25 | — | 0.1% | ||
| Q3 25 | 14.0% | 101.1% | ||
| Q2 25 | 14.0% | 440.0% | ||
| Q1 25 | 9.2% | 4507.1% | ||
| Q4 24 | 77.4% | 378600.0% | ||
| Q3 24 | 19.4% | 59266.7% | ||
| Q2 24 | 13.1% | 6980.0% | ||
| Q1 24 | 22.9% | 2535.7% |
| Q4 25 | — | 1.47× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ELME
| Residential Segment | $57.7M | 93% |
| Other | $4.4M | 7% |
FDMT
Segment breakdown not available.
